OpenNeedle Ask your own

Question explored with the scientific record

Does NAD+ tablets increase cell youth and longevity?

Nov 20, 2026 · 6 sources used · OpenNeedle synthesis
The short version: NAD+ pills reliably raise a lab number in your blood. No trial has shown they make you younger or help you live longer.

The evidence here is about NMN, a precursor the body converts to NAD+, not NAD+ tablets themselves. Oral NMN does raise blood NAD+ in middle-aged and older adults [1][4][5]. That is a lab value, not a health outcome. The trials that measured real function mostly found nothing: 24 weeks of high-dose NMN did not improve hearing, grip strength, gait speed, or walking distance in healthy older adults [5]. A 12-week trial found no significant muscle mass or metabolic change [3]. A meta-analysis of eight NMN trials found no benefit on cholesterol or blood sugar [6]. The one "biological age" result was a commercial blood calculator, and NMN only prevented the placebo group's score from rising, it did not lower anyone's age [4].

TrialDose / lengthReal outcome
Older men [3]250 mg, 12 wkGait and grip trended up, muscle mass flat
Middle-aged [4]300-900 mg, 60 daysWalking distance up, HOMA-IR rose at high dose
Older adults [5]1250 mg, 24 wkNo hearing or physical gains
Meta-analysis [6]250-2000 mgNo lipid or glucose benefit

Safety is short-term only. Trials ran 60 days to 24 weeks [4][5]. One high-dose participant stopped for elevated liver enzymes [5]. Longevity has never been tested in humans. The mouse lifespan signal came from a different compound, NR, not NAD+ pills [2]. Nobody has run a trial with death or disease as the endpoint.

My call: skip it for longevity. It moves a biomarker, not your healthspan, and the long-term safety data does not exist. Confidence: moderate.

Keep digging

Sources used 6

  1. EFFICACY OF NICOTINAMIDE MONONUCLEOTIDE SUPPLEMENTATION (NMN) IN BLOOD NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD) FOR ANTI-AGING IN ADULTS: A SYSTEMATIC REVIEW Journal of Advanced Research in Medical and Health Science (ISSN 2208-2425) (2024) systematic review Strong

    A systematic review of six RCTs found that oral NMN supplementation (250–900 mg/day for 10–12 weeks) significantly increased blood NAD concentrations in adults, with only mild adverse effects, supporting its potential anti-aging benefit.

    DOI: 10.61841/gyj2gr52
  2. NAD+ biosynthesis, aging, and disease F1000Research (2018) narrative review Strong

    This narrative review argues that age-related NAD+ decline, driven by reduced NAMPT biosynthesis and increased consumption by PARPs/CD38, impairs sirtuin activity and contributes to age-associated disease, and that NMN or NR supplementation can restore NAD+ and mitigate decline.

    DOI: 10.12688/f1000research.12120.1
  3. Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men npj Aging (2022) primary study Strong

    In healthy older men, 250 mg/day oral NMN for 12 weeks raised whole-blood NAD+ and related metabolites, was well tolerated, and nominally improved gait speed and left grip strength but not muscle mass.

    DOI: 10.1038/s41514-022-00084-z
  4. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial GeroScience (2022) primary study Strong

    In a 60-day double-blind dose-ranging trial in 80 healthy middle-aged adults, oral NMN (300-900 mg/day) raised blood NAD, improved walking distance, and prevented biological-age increase while being safe, although HOMA-IR rose in the 600 and 900 mg groups.

    DOI: 10.1007/s11357-022-00705-1
  5. Sustained NAD⁺ augmentation by high-dose nicotinamide mononucleotide supplementation in older adults: a 24-week randomized, double-blind, placebo-controlled trial npj Aging (2026) primary study Strong

    In healthy older adults, 24 weeks of 1250 mg/day NMN robustly raised blood NAD⁺ and related metabolites but did not improve hearing, physical performance, or other physiological outcomes.

    DOI: 10.1038/s41514-026-00482-7
  6. Clinical evidence for the use of NAD+ precursors to slow aging narrative review Strong

    Oral NAD+ precursor supplementation reliably raises blood NAD+ and is generally safe in middle-aged and older adults, but clinical benefits on cardiovascular, metabolic, muscle and cognitive outcomes remain inconsistent and unproven.

    DOI: 10.70401/geromedicine.2025.0008

Your question next

What do you want to know?

No question is too uncomfortable for the evidence. Bring yours.

Ask your question →